SciELO - Scientific Electronic Library Online

 
vol.66 issue4Clinical practice guideline for the prevention, early detection and treatment of pregnancy, delivery and post-partum complications: section 3. Infections in pregnancy: premature rupture of membranes (PROM)Vulvar and perineal injury secondary to complex pelvic and perineal trauma: case presentation and review of the literature author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Obstetricia y Ginecología

Print version ISSN 0034-7434

Abstract

ARIAS-BLANCO, Juan Felipe et al. Frequency of sequence mutations and variants for the BRCA1 and BRCA2 genes in a sample of Colombian women with suspected hereditary breast cancer syndrome: Case series. Rev Colomb Obstet Ginecol [online]. 2015, vol.66, n.4, pp.287-296. ISSN 0034-7434.  http://dx.doi.org/10.18597/rcog.294.

Objective: To describe sequence variants in the BRCA1 and BRCA2 genes in a sample of Colombian patients with a personal or family history of breast cancer suggestive of genetic risk. Materials and methods: Case series consisting of 67 patients referred for genetic testing because of suspected hereditary breast and ovarian cancer syndrome (HBOC). Of the 67 cases, 42 (62.7%) met the medical indication criteria of the 2013 National Comprehensive Cancer Network (NCCN) and they were subjected to the entire sequencing of the BRCA1 and BRCA2 genes. A determination was made of the frequency of sequence mutation, variants, and of the clinical significance of the variants found based on the Breast Cancer Information Core (BIC). Results: Mutations were identified for the BRCA 1 gene in six patients (14.3%), no mutation was documented for the BRCA 2 gene, and 43 genetic variants were found in 27 patients (64.2% of 42 cases). Of these, 21 (48.8%) were identified in the BRCA1 gene and 22 (51.2%) in the BRCA 2 gene. Among these variants, 5 pathogenic mutations were found only in the BRCA1 gene and, of those, only 1 had been reported previously in Colombia. Conclusions: This study identifies pathogenic genetic variants in the BRCA1 gene not described previously in the Colombian population, as well as others known in different populations. Therefore, it helps expand knowledge regarding the variants of the BRCA1 and BRCA2 genes in the Colombian population. However, additional studies are required with sufficient power and methodological quality to estimate the frequency of sequence mutations and variants for the BRCA1 and BRCA2 genes in Colombian women suspected of having the hereditary breast or ovarian cancer syndrome.

Keywords : Breast cancer; BRCA 1; BRCA 2; gene mutation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )